Author

O. Cil

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

A. M. Harrington· 1 shared A. M. Trumbull· 1 shared C. Kuo· 1 shared D. Julius· 1 shared F. Deng· 1 shared J. B. Sarthi· 1 shared J. E. Chan· 1 shared J. Gammons· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. M. Harrington

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Crypt and Villus Enterochromaffin Cells are Distinct Stress Sensors in the Gut

K. K. Touhara, N. D. Rossen, F. Deng, T. Chu, A. M. Harrington, S. Garcia Caraballo, M. Brizuela, T. O'Donnell, O. Cil, S. M. Brierley, Y. Li, D. Julius

This study identifies distinct roles for crypt and villus enterochromaffin cells in sensing gut irritants and oxidative stress through different TRP channels and signaling mechanisms.

bioRxiv · Feb 6, 2024Physiology

Key role of down-regulated in adenoma (SLC26A3) chloride/bicarbonate exchanger in linaclotide-stimulated intestinal bicarbonate secretion upon loss of CFTR function

J. B. Sarthi, A. M. Trumbull, S. M. Abazari, V. van Unen, J. E. Chan, Y. Jiang, J. Gammons, M. O. Andrerson, O. Cil, C. Kuo, Z. M. Sellers

This study shows linaclotide stimulates bicarbonate secretion in CFTR-deficient tissues by enhancing DRA expression, suggesting DRA as a therapeutic target for CF-related intestinal dysfunction.

bioRxiv · May 5, 2023 · PreprintPhysiology